HepatitisInfo Center
Hepatitis A Avoids the Immune System
Just when researchers were attributing hepatitis C's ability to become chronic was due to its superior ability to avoid the immune system, a new discovery was made. Hepatitis A can linger, too in the body for up to a year.
Hepatitis C Patients And Prevention
Along with an emerging mantra of improved health via diet and exercise, another emphasis should now be added: Prevention, in this case, prevention of hepatitis C.
coffee helps hepatitis c treatment response
"Coffee intake has been associated with a lower level of liver enzymes, reduced progression of chronic liver disease and reduced incidence of liver cancer," said Neal Freedman, PhD, MPH, of the National Cancer Institute and lead author of this study. "Although we observed an independent association between coffee intake and virologic response to treatment, this association needs replication in other studies."
Among non-drinkers, 46 percent had an early virologic response; 26 percent had no detectable serum hepatitis C virus (HCV) ribonucleic acid at week 20; 22 percent had no detectable...
Two New Hepatitis C Drugs Butt Marketing Heads
Hepatitis C virus (HCV) is an infectious disease which is 100 times more infectious than HIV. People who inject drugs or engage in unprotected sex account for most people who are infected with hepatitis C.
New Drug Mix for Hepatitis C
The current two-drug treatment for hepatitis C does not work as well as patients would like.
Now, researchers have found that adding a third drug to the mix leads to better results.
Help is Here, but You Aren't Eligible
Lack of health insurance coverage may affect hepatitis C patients' access to current antiviral treatments, according to a new study.
When Hepatitis A Turns Fatal
A study from South Korea has found a link between the Hepatitis A virus and patients with pre-existing chronic liver disease and identified the age group most at risk.
The Critical Interim
Scientists have created an antibody to remove the Hepatitis C virus from the bloodstream during liver transplant surgery in an effort to prevent re-infection of the organ, a problem that occurs in most cases.
New Biomarker Found for Hepatitis C
Scientists find new ways to predict the efficiency of Hepatitis C treatments by singling out a particular protein that, in its abnormal form, impedes immune response instead of helping it.